Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Jazz Pharmaceuticals
Jazz Pharmaceuticals
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
Merck acquires $700m clinical-stage bispecific antibody from Curon Biopharmaceutical
The CD3xCD19-targeting T-cell engager is currently being evaluated in Phase I/Ib/II clinical trials for a range of B-cell malignancies
Coating coin-shaped cores: a downstream technology solution to reduce tablet capping
When it come to reducing the incidence of tablet capping or delamination, the use of flat-faced or coin-shaped cores offers several benefits compared with biconvex ones....
PacBio teams up with Singapore's NPM programme to sequence genomes
The organisations will sequence a number of genomes throughout the Singaporean population and aims to improve patient outcomes
Ingersoll Rand acquires Hi-line Industries for cleaner compressed air
The acquisition will allow Hi-line to boost its IoT capabilities, while also expanding its global footprint and customer base
Causes and solutions for dark spots in tablet manufacturing
Natoli Engineering examines the causes and solutions for dark spots that can halt production
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Jazz Pharmaceuticals announces UK manufacturing investment
Due to open in 2024, the facility is designed to support the company’s two cannabis-based medicines and support future capacity for medicines under development
Regulatory
Hikma enters settlement agreement with Jazz for sodium oxybate
Jazz will grant Hikma and West-Ward the right to sell an authorised generic of Xyrem in the US
Design & Build
Jazz Pharmaceuticals among ISPE FOYA winners
Ardmac supplied and installed the cleanroom in the biopharmaceutical company's winning facility in Ireland
Finance
Jazz Pharmaceuticals buys Alize Pharma II for €18m
Alize Pharma II is developing treatments for acute lymphoblastic leukaemia
Pharmaceutical
Jazz Pharmaceuticals names Russell Cox as Chief Operating Officer
Cox was formerly EVP and Chief Commercial Officer at the biopharmaceuticals company
Manufacturing
Jazz Pharmaceuticals to build new manufacturing and development facility in Ireland
It is expected to open in 2016 and create up to 50 new jobs when fully operational
Ingredients
Jazz Pharmaceuticals moves to buy EUSA Pharma
Terms include $650 million in cash plus a potential $50 m milestone payment
Subscribe now